Tag: Trillium Therapeutics Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Trillium Therapeutics Inc.

Trillium Therapeutics Inc (TRIL) Expected to Post Earnings of -$0.66 Per Share

Added to Collection on: 2019-03-05 00:15:56

Tags for this article:

Money
Finance
Economy
Financial ratios
Fundamental analysis
Earnings per share
Financial analyst
Securities research
Trillium Therapeutics Inc.
Price–earnings ratio

Click the tags to see associated articles and topics

View Article Details
Trillium Therapeutics (TRIL) Stock Price Up 5.1%

Added to Collection on: 2019-03-05 09:41:15

Tags for this article:

Stock
Day trading
Trillium Therapeutics Inc.
TRIL

Click the tags to see associated articles and topics

View Article Details
Trillium Therapeutics (TRIL) Shares Up 5.1%

Added to Collection on: 2019-03-07 02:11:15

Tags for this article:

Trillium Therapeutics Inc.
TRIL

Click the tags to see associated articles and topics

View Article Details
Trillium Therapeutics (TRIL) Sees Strong Trading Volume

Added to Collection on: 2019-03-08 09:07:30

Tags for this article:

Money
Finance
Hedge fund
Economy
Stock
Equity securities
Alternative investment management companies
Trillium Therapeutics Inc.
TRIL

Click the tags to see associated articles and topics

View Article Details
Investors Secrets on Trillium Therapeutics Inc. (TRIL), Infosys Limited (INFY)

Added to Collection on: 2019-03-26 00:52:30

Tags for this article:

Finance
Economy
Relative strength index
Infosys
NASDAQ
Stock market
Share trading
Financial markets
MACD
Trillium Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Trillium Therapeutics (NASDAQ:TRIL) Rating Reiterated by Cowen

Added to Collection on: 2019-09-06 07:15:00

Tags for this article:

Economy
Stock
Financial economics
Flora of the United States
Corporations
Trillium Therapeutics Inc.
Flora of Canada
Trillium

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal ...

Added to Collection on: 2020-11-20 15:54:02

Tags for this article:

Companies
Life Sciences
Biotechnology
Regenerative biomedicine
Amarin Corporation
Gilead Sciences
NASDAQ
Mesoblast
United Therapeutics
Pfizer
AstraZeneca
Corcept Therapeutics
Prelude Therapeutics Inc
China Biologic Products
TRACON Pharmaceuticals Inc
ALX Oncology Holdings Inc
Spruce Biosciences Inc
Atara Biotherapeutics Inc.
Trillium Therapeutics Inc.
Infinity Pharmaceuticals Inc.
Travere Therapeutics Inc.
Twist Bioscience Corp
Corcept Therapeutics Incorporated
Rocket Pharmaceuticals Inc
REPLIMUNE GROUP, INC
Biotech Ltd
Idera Pharmaceuticals Inc
Pacira Biosciences Inc

Click the tags to see associated articles and topics

View Article Details
Cormorant Asset Management, LLC Buys Forma Therapeutics Holdings Inc, Avidity Biosciences ...

Added to Collection on: 2020-11-21 05:37:30

Tags for this article:

Finance
Financial economics
Money
Corporate finance
Stock
Stock market
Financial markets
Avidity Biosciences Inc.
ZYMEWORKS INC
Forma Therapeutics Holdings Inc
Immunovant Inc.
Trillium Therapeutics Inc.
Myokardia Inc

Click the tags to see associated articles and topics

View Article Details
Trillium Therapeutics Inc. (NASDAQ:TRIL) Receives Average Rating of "Hold" from Analysts

Added to Collection on: 2020-12-12 12:33:43

Tags for this article:

Flora of Canada
Flora of the United States
Trillium
Short
Economy
Trillium Therapeutics Inc.
NASDAQ COMPOSITE INDEX

Click the tags to see associated articles and topics

View Article Details
What Kind Of Investors Own Most Of Trillium Therapeutics Inc. (TSE:TRIL)?

Added to Collection on: 2021-01-19 17:48:45

Tags for this article:

Finance
Money
Financial economics
Equity securities
Stock market
Corporate finance
Investment
Shareholders
Hedge fund
Stock
Trillium
Institutional investor
Trillium Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo